You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-DNA

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)

Completed
  • HIV-1-infection
  • PENNVAX-GP
  • +3 more
  • Los Angeles, California
  • +1 more
Apr 4, 2022

HIV Trial in San Francisco (DNA CON-S env, IHV01, Placebo)

Withdrawn
  • HIV Infections
  • DNA CON-S env
  • +2 more
  • San Francisco, California
    Bridge HIV CRS
Oct 13, 2021

HIV Trial in Birmingham, San Francisco, Seattle (pGA2/JS2 Plasmid DNA Vaccine)

Completed
  • HIV Infections
  • pGA2/JS2 Plasmid DNA Vaccine
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)

Completed
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Ixazomib 1 MG
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 8, 2021

HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)

Not yet recruiting
  • HIV Infections
  • sD-NP-GT8 DNA
  • +4 more
  • Birmingham, Alabama
  • +5 more
Mar 10, 2023

HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

Recruiting
  • HIV Infections
  • HIVIS DNA/MVA-CMDR
  • +2 more
  • Tygerberg Hills, Cape Town, South Africa
    Stellenbosch University
Apr 20, 2022

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

Active, not recruiting
  • HIV Infections
  • env (A,B,C,A/E)/gag (C) DNA Vaccine
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

Withdrawn
  • HIV Infections
  • VRC-HIVDNA016-00-VP
  • +3 more
  • (no location specified)
Oct 28, 2021

HIV Trial in Chapel Hill, Durham (Nelfinavir mesylate, Lamivudine, Filgrastim)

Completed
  • HIV Infections
  • Nelfinavir mesylate
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2021

HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

Active, not recruiting
  • HIV Infections
  • Env-C Plasmid DNA
  • +6 more
  • Kericho, Kenya
    Kenya Medical Research Institute/Walter Reed Project, Clinical R
Feb 25, 2022

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    Cervix Cancer, HPV Infection, Cervical High Grade Squamous Intraepithelial Lesion Trial in São Paulo, Cuernavaca (Xpert HPV, S5

    Recruiting
    • Cervix Cancer
    • +3 more
    • Xpert HPV
    • S5 DNA methylation classifier
    • São Paulo, Brazil
    • +1 more
    Aug 14, 2023

    Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)

    Not yet recruiting
    • Tuberculosis
    • Quantiferon Gold
    • +5 more
    • (no location specified)
    Oct 27, 2023

    HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

    Withdrawn
    • HIV Infections
    • GEO-D03 DNA Vaccine
    • +3 more
    • (no location specified)
    Nov 4, 2021

    HIV-1 Infection Trial in Montpellier (HIV DNA)

    Completed
    • HIV-1 Infection
    • HIV DNA
    • Montpellier, France
      University hospital Montpellier
    Jul 5, 2021

    HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

    Completed
    • HIV Infections
    • DNA Nat-B env
    • +7 more
    • Birmingham, Alabama
    • +6 more
    Oct 13, 2021

    HIV Trial in United States (PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo)

    Completed
    • HIV Infections
    • PENNVAX®-GP HIV-1 DNA vaccine
    • +2 more
    • Decatur, Georgia
    • +3 more
    Oct 13, 2021

    HIV Trial in United States (AIDSVAX B/E Vaccine, DNA-HIV-PT123 Vaccine, Placebo for DNA-HIV-PT123)

    Completed
    • HIV Infections
    • AIDSVAX B/E Vaccine
    • +3 more
    • San Francisco, California
    • +6 more
    Oct 13, 2021

    HIV Trial in Rochester, Philadelphia, Nashville (PENNVAX-B, IL-12 DNA plasmids)

    Completed
    • HIV Infections
    • PENNVAX-B
    • IL-12 DNA plasmids
    • Rochester, New York
    • +2 more
    Oct 13, 2021

    HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)

    Completed
    • HIV Infections
    • GEO-D03 DNA vaccine
    • +3 more
    • Birmingham, Alabama
    • +3 more
    Oct 13, 2021

    HIV Trial (DNA Nat-B env vaccine, NYVAC Nat-B env vaccine, DNA CON-S env vaccine)

    Withdrawn
    • HIV Infections
    • DNA Nat-B env vaccine
    • +7 more
    • (no location specified)
    Oct 13, 2021

    HIV Trial (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

    Withdrawn
    • HIV Infections
    • DNA-HIV-PT123 vaccine
    • +4 more
    • (no location specified)
    Oct 13, 2021

    HIV Trial (DermaVir patch, Placebo patch)

    Withdrawn
    • HIV Infections
    • DermaVir patch
    • Placebo patch
    • (no location specified)
    Oct 28, 2021

    HIV Trial (GEO-D02 DNA, MVA/HIV62B Vaccine, B63521^11 gp120)

    Withdrawn
    • HIV Infections
    • GEO-D02 DNA
    • +4 more
    • (no location specified)
    Oct 13, 2021